Trials / Conditions / Fascioscapulohumeral Muscular Dystrophy Type 2
Fascioscapulohumeral Muscular Dystrophy Type 2
3 registered clinical trials studyying Fascioscapulohumeral Muscular Dystrophy Type 2 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD NCT07038200 | Avidity Biosciences, Inc. | Phase 3 |
| Enrolling By Invitation | Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FS NCT06547216 | Avidity Biosciences, Inc. | Phase 2 |
| Active Not Recruiting | Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) NCT05747924 | Avidity Biosciences, Inc. | Phase 1 / Phase 2 |